EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity

Esmeralda Juárez iD, Elizabeth Ortiz iD, Ningel Omar Gama, Andy Ruiz iD, Silvia Guzmán-Beltrán iD, Wendy Arias iD, Miguel Angel Aguilar-Méndez, Eduardo San Martin-Martínez iD, Horacio Vieyra iD

Polymers · 24.07.2026 · 18 (15) · 1814

DOI: 10.3390/polym18151814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polymers, online erschienen am 24.07.2026. Verfasst von Esmeralda Juárez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Alta Contención Biológica, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calz. de Tlalpan 4502, Sección XVI,…. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia Tecnología e Innovación, Tecnológico de Monterrey, Instituto Politécnico Nacional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor adherence to prolonged antibiotic regimens remains a major challenge in the treatment and prevention of chronic infectious diseases such as tuberculosis. Transdermal drug delivery systems capable of sustained antibiotic release may improve therapeutic compliance while reducing the need for frequent oral administration. In this study, electrospun polymeric membranes based on poly(lactic acid) (PLA) and poly(ε-caprolactone) (PCL) were developed as transdermal rifampicin delivery platforms. Homogeneous nanofibrous membranes with average fiber diameters of approximately 250 nm were successfully fabricated and exhibited efficient drug incorporation while preserving the structural integrity of the polymeric matrix. The electrospun membranes retained sufficient tensile strength and dimensional stability after accelerated temperature–humidity aging, supporting their stability during storage, handling, and application. In vitro cytotoxicity and biocompatibility assays using primary human peripheral blood mononuclear cells (PBMCs) demonstrated that the developed systems did not induce significant cytotoxic or pro-inflammatory responses. Transdermal permeation studies using an in vitro mouse skin model demonstrated sustained rifampicin diffusion for at least 72 h. Importantly, the antibiotic recovered after skin permeation preserved antimycobacterial activity against Mycobacterium tuberculosis H37Ra and Mycobacterium bovis BCG, confirming that rifampicin maintained its biological functionality after electrospinning and transdermal migration. Overall, these findings demonstrate the potential of electrospun PLA/PCL membranes as stable and biocompatible transdermal antibiotic delivery systems capable of sustained release and preservation of antimicrobial activity. This proof-of-concept study supports the translational potential of electrospun polymeric platforms for controlled antibiotic delivery in long-term infectious disease therapies.

Schlagwörter

Stichwörter der Autor:innen

biomedical patchesdrug delivery systemselectrospinningpoly(ε-caprolactone)polylactic acidrifampicintuberculosis

Autor:innen und Institutionen

  • Laboratorio de Alta Contención Biológica, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calz. de Tlalpan 4502, Sección XVI, Tlalpan, Ciudad de México 14080, Mexico.
  • Tecnológico de Monterrey, Escuela de Ingeniería y Ciencias, Eduardo Monroy Cárdenas 2000, San Antonio Buenavista, Toluca de Lerdo 50110, Mexico.
  • Centro de Investigación en Ciencia Aplicada y Tecnología Avanzada, Instituto Politécnico Nacional, Legaria 694, Colonia Irrigación, Ciudad de México 11500, Mexico.
  • Departamento de Investigación en Microbiología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calz. de Tlalpan 4502, Sección XVI, Tlalpan, Ciudad de México 14080, Mexico.

ORCID-Profile: Esmeralda Juárez, Elizabeth Ortiz, Andy Ruiz, Silvia Guzmán-Beltrán, Wendy Arias, Eduardo San Martin-Martínez, Horacio Vieyra

Förderung

  • Secretaría de Ciencia Tecnología e Innovación
  • Tecnológico de Monterrey
  • Instituto Politécnico Nacional
  • la Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México

Zitieren

APA

Juárez, E., Ortiz, E., Gama, N. O., Ruiz, A., Guzmán-Beltrán, S., Arias, W., Aguilar-Méndez, M. A., San Martin-Martínez, E., & Vieyra, H. (2026). Electrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity. Polymers, 18(15), 1814. https://doi.org/10.3390/polym18151814

Vancouver

Juárez E, Ortiz E, Gama NO, Ruiz A, Guzmán-Beltrán S, Arias W, et al. Electrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity. Polymers. 2026;18(15):1814. doi:10.3390/polym18151814

BibTeX
@article{Jurez2026,
  author = {Juárez, Esmeralda and Ortiz, Elizabeth and Gama, Ningel Omar and Ruiz, Andy and Guzmán-Beltrán, Silvia and Arias, Wendy and Aguilar-Méndez, Miguel Angel and San Martin-Martínez, Eduardo and Vieyra, Horacio},
  title = {Electrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity},
  journal = {Polymers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {1814},
  doi = {10.3390/polym18151814}
}
Kostenlos starten →